Repligen corporation

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological repligen corporation manufacturing process in North America, Europe, the Asia Pacific, and internationally.

Powered by. Repligen Corp Repligen is a life science company that develops and commercializes bioprocessing technologies for the manufacturing of biological drugs. Its products include upstream and downstream filtration, chromatography products, fluid management, cell culture supplements, ligands, and operating room disposables. The company also provides solutions to overcome the development and production of modalities into a new class of drugs. Its services comprise hands-on-process and implementation consultation services.

Repligen corporation

Overcome common challenges. Push the boundaries of what's possible. Maximize productivity at every step. Simplify complex workflows. Accelerate new modalities. Leverage technology breakthroughs and expert engineering. See how it works. Repligen is revolutionizing how modern chromatography is performed. The result? Unprecedented recovery and operational efficiencies even with the most complex modalities. The PAT landscape in upstream intensification, the benefits of this approach, and the scale-up from benchtop to manufacturing is discussed.

Visit Corporate Site. Solutions for new modalities.

Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. Before , Repligen maintained dual capabilities in developing pharmaceutical therapeutics drug discovery and development and the development of materials supporting biological drug manufacture bioprocessing business. Repligen employs a direct sales model to users of its products in the United States, with some sales through intermediaries in "certain foreign markets". As a consequence of current operations, about one-third each of revenue and cost and expenses are denominated in Swedish krona currency, the remaining two-thirds denominated in United States dollars ; this presents a risk to the business based on unpredictable fluctuations in currency exchange rates. The company's Protein A-related offerings are supported by proprietary technology, trade secrets and patent filings. Repligen's company headquarters are housed together with its manufacturing facility in Waltham, Massachusetts. Repligen maintains manufacturing facilities in Waltham, Massachusetts and Lund, Sweden.

We saw strong ratings and rankings as a result and are pleased to share this next progress report, while continuing to work toward positively impacting some of our more challenging initiatives and collaboration-based goals. Below are just a few of the Sustainability Report highlights. Report data is through year end unless otherwise noted. About Repligen Corporation Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U. For more information, please visit www. Forward Looking Statements This press release may contain forward-looking statements within the meaning of the federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including risks discussed from time to time in our filings with the Securities and Exchange Commission.

Repligen corporation

Tony J. Strategically, we executed on two important deals, signing a year agreement with DRS Daylight Solutions on real-time process monitoring using mid-infrared technology and more recently extending our affinity ligand relationship with Purolite an EcoLab company until Our financial guidance for the fiscal year is based on expectations for our existing business and includes the financial impact of our acquisitions. This guidance also excludes the impact of potential additional acquisitions and future fluctuations in foreign currency exchange rates. Repligen will host a conference call and webcast today, November 1, , at a. EDT, to discuss third quarter financial results, financial guidance and corporate developments. The conference call will be accessible by dialing toll-free for domestic callers or for international callers.

Salt and sacrifice cheat engine

Welcome FlexBiosys! September 27, Website www. Viral vector N-1 intensification reduces seed train vessel number, media volume and time. Traded as. Join the Repligen team Working at Repligen means being part of a team that is excited to find new and creative ways to overcome challenges in bioprocessing — and to help our customers make a difference in the world. Rich had been a member of the Board since Waltham, Massachusetts , United States. No of Employees 2, News Solutions for new modalities.

Tony J. Strategically, our three acquisitions of Polymem, Avitide and BioFlex position us well to continue to drive above market growth in Our financial guidance for the fiscal year is based on expectations for our existing business and includes the financial impact of our acquisitions of BioFlex Solutions which closed on December 16, , Avitide Inc.

Public company. The result? In , an agreement was struck to divest certain intellectual property rights to Bristol-Myers Squibb around the drug Orencia in exchange for ongoing royalty payments through the end of History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events. The reason given is: hasn't been materially touched since Biotechnology company. Book consultation. Buy Report View Sample. Overcome common challenges. Read Edit View history. Watch webinar. Pay is salary, bonuses, etc. Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. Hunt President and CEO. Chromatography Redesigned Repligen is revolutionizing how modern chromatography is performed.